Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CABANASDAQ:MSPRNASDAQ:NHNASDAQ:SY On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCABACabaletta Bio$1.79+3.5%$1.62$0.99▼$9.05$90.83M2.811.63 million shs1.48 million shsMSPRMSP Recovery$1.27-8.6%$1.70$1.10▼$14.55$10.47M-2.4950,130 shs36,443 shsNHNantHealth$0.01+9,900.0%$0.01$1.24▼$9.75$77K1.8238,073 shsN/ASYSo-Young International$1.17+15.8%$0.87$0.66▼$1.26$118.68M1.01125,534 shs958,867 shsOptions Trading Made Easy - Download NowLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCABACabaletta Bio0.00%-10.05%+0.56%+2.87%-78.56%MSPRMSP Recovery0.00%-11.19%-8.63%-2.31%+126,999,900.00%NHNantHealth+222.58%+222.58%+222.58%+376.19%-98.33%SYSo-Young International0.00%+21.99%+36.36%+13.59%+13.58%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCABACabaletta Bio2.6193 of 5 stars4.51.00.00.02.00.80.6MSPRMSP RecoveryN/AN/AN/AN/AN/AN/AN/AN/ANHNantHealthN/AN/AN/AN/AN/AN/AN/AN/ASYSo-Young International0.4205 of 5 stars1.03.00.00.00.70.80.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCABACabaletta Bio 3.00Buy$14.43706.07% UpsideMSPRMSP Recovery 0.00N/AN/AN/ANHNantHealth 0.00N/AN/AN/ASYSo-Young International 2.00Hold$0.80-31.62% DownsideCurrent Analyst Ratings BreakdownLatest NH, SY, MSPR, and CABA Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/11/2025CABACabaletta BioHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$25.005/16/2025CABACabaletta BioCitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$17.00 ➝ $13.005/15/2025CABACabaletta BioGuggenheimSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$23.00 ➝ $25.004/1/2025CABACabaletta BioWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetEqual Weight ➝ Equal Weight$6.00 ➝ $3.004/1/2025CABACabaletta BioUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$10.00 ➝ $7.004/1/2025CABACabaletta BioGuggenheimSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$23.00 ➝ $23.004/1/2025CABACabaletta BioMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOverweight ➝ Overweight$30.00 ➝ $22.004/1/2025CABACabaletta BioHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$25.00 ➝ $25.00(Data available from 6/22/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCABACabaletta BioN/AN/AN/AN/A$3.12 per shareN/AMSPRMSP Recovery$13.09M0.80$63.50 per share0.02($17.97) per share-0.07NHNantHealth$67.68M0.00N/AN/A($30.72) per share0.00SYSo-Young International$200.94M0.59$0.01 per share101.40$2.63 per share0.44Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCABACabaletta Bio-$115.86M-$2.54N/AN/AN/AN/A-78.29%-65.68%8/6/2025 (Estimated)MSPRMSP Recovery-$360.50M-$142.50N/A∞N/A-3,540.07%-326.80%-48.26%N/ANHNantHealth-$67.78M-$7.65N/A∞N/A-94.67%N/A-39.82%N/ASYSo-Young International-$80.76M-$0.80N/A∞N/A-41.03%-2.14%-1.61%8/20/2025 (Estimated)Latest NH, SY, MSPR, and CABA EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/21/2025Q1 2025CABACabaletta Bio-$0.67-$0.71-$0.04-$0.71N/AN/A5/16/2025Q1 2025SYSo-Young International-$0.34-$0.04+$0.30-$0.04$293.76 million$40.95 million5/15/2025Q1 2025MSPRMSP RecoveryN/A-$33.70N/A-$33.70N/A$0.84 million3/31/2025Q4 2024CABACabaletta Bio-$0.65-$0.65N/A-$0.65N/AN/A3/28/2025Q4 2024SYSo-Young International$0.0906-$0.07-$0.1606-$0.81$402.58 million$50.57 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCABACabaletta BioN/AN/AN/AN/AN/AMSPRMSP RecoveryN/AN/AN/AN/AN/ANHNantHealthN/AN/AN/AN/AN/ASYSo-Young InternationalN/AN/AN/AN/AN/ALatest NH, SY, MSPR, and CABA DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date3/28/2025SYSo-Young International--$0.02254/8/20254/8/20254/25/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCABACabaletta BioN/A3.963.96MSPRMSP Recovery0.850.020.02NHNantHealthN/A0.640.64SYSo-Young InternationalN/A2.752.45Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCABACabaletta BioN/AMSPRMSP Recovery3.77%NHNantHealth4.50%SYSo-Young International35.31%Insider OwnershipCompanyInsider OwnershipCABACabaletta Bio11.25%MSPRMSP Recovery75.17%NHNantHealth61.30%SYSo-Young International16.70%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCABACabaletta Bio5050.74 million45.03 millionOptionableMSPRMSP Recovery38.24 million2.05 millionN/ANHNantHealth3407.70 million2.98 millionNot OptionableSYSo-Young International1,800101.44 million84.50 millionNot OptionableNH, SY, MSPR, and CABA HeadlinesRecent News About These CompaniesSo-Young International Stock Set to Reverse Split on Monday, June 30th (NASDAQ:SY)June 22 at 1:13 AM | marketbeat.comSo-Young International Inc.: So-Young Announces Extension of Plan to Implement ADS Ratio ChangeJune 20 at 3:54 PM | finanznachrichten.deSo-Young Announces Extension of Plan to Implement ADS Ratio ChangeJune 20 at 5:00 AM | prnewswire.comLifeMD (NASDAQ:LFMD) & So-Young International (NASDAQ:SY) Critical SurveyJune 20 at 2:23 AM | americanbankingnews.comSo-Young International (NASDAQ:SY) Stock Price Down 5% - Here's What HappenedJune 1, 2025 | marketbeat.comSo-Young announces plan to implement ADS ratio change, shares downMay 30, 2025 | msn.comSo-Young Announces Plan to Implement ADS Ratio ChangeMay 30, 2025 | prnewswire.comSo-Young International Inc. (NASDAQ:SY) Q1 2025 Earnings Call TranscriptMay 20, 2025 | insidermonkey.comQ1 2025 So-Young International Inc Earnings CallMay 17, 2025 | finance.yahoo.comSo-Young International reports Q1 revenue decline, shares edge lowerMay 16, 2025 | in.investing.comSo-Young International Inc. (SY) Q1 2025 Earnings Call TranscriptMay 16, 2025 | seekingalpha.comSo-Young Reports Unaudited First Quarter 2025 Financial ResultsMay 16, 2025 | prnewswire.comSo-Young to Report First Quarter 2025 Financial Results on May 16, 2025May 6, 2025 | prnewswire.comSo-Young International Inc. Files Its Annual Report on Form 20-FApril 18, 2025 | gurufocus.comSo-Young International Inc. Files Its Annual Report on Form 20-F | SY Stock NewsApril 18, 2025 | gurufocus.comSo-Young International Inc. Files Its Annual Report on Form 20-FApril 18, 2025 | prnewswire.comSo-Young controlling shareholder purchases $4.09M in sharesApril 2, 2025 | markets.businessinsider.comSo-Young’s CEO Increases Stake with Major Share PurchaseApril 2, 2025 | tipranks.comSo-Young International Inc. Announces Share Purchase by Controlling ShareholderApril 2, 2025 | prnewswire.comSo-Young International Inc.: So-Young Reports Unaudited Fourth Quarter and Fiscal Year 2024 Financial ResultsMarch 30, 2025 | finanznachrichten.deQ4 2024 So-Young International Inc Earnings CallMarch 29, 2025 | uk.finance.yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All Headlines3 Stocks Getting Rare Double Upgrades From AnalystsBy Chris Markoch | June 6, 2025View 3 Stocks Getting Rare Double Upgrades From Analysts3 Trades Members of Congress Are Making Right NowBy Chris Markoch | May 23, 2025View 3 Trades Members of Congress Are Making Right NowLululemon, UNH, Enphase: Bad News, Good Opportunity?By Thomas Hughes | June 17, 2025View Lululemon, UNH, Enphase: Bad News, Good Opportunity?3 Oversold Stocks Flashing Bullish Reversal SignalsBy Sam Quirke | June 7, 2025View 3 Oversold Stocks Flashing Bullish Reversal SignalsThese ETFs Provide Easy Exposure to Growing International MarketsBy Nathan Reiff | May 24, 2025View These ETFs Provide Easy Exposure to Growing International MarketsNH, SY, MSPR, and CABA Company DescriptionsCabaletta Bio NASDAQ:CABA$1.79 +0.06 (+3.47%) Closing price 06/20/2025 04:00 PM EasternExtended Trading$1.78 -0.01 (-0.61%) As of 06/20/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. The company's lead product candidate is CABA-201, a fully human anti-CD19 binder for the treatment of Phase 1/2 clinical trials in dermatomyositis, anti-synthetase syndrome, immune-mediated necrotizing myopathy, lupus nephritis, non-renal systemic lupus erythematosus, systemic sclerosis, and generalized myasthenia gravis. It also develops DSG3-CAART, which is in Phase I/II clinical trial for the treatment of mucosal pemphigus vulgaris; and MuSK-CAART, an investigational cell therapy that is in Phase I/II clinical trial for treating patients with anti- muscle-specific kinase antibody positive myasthenia gravis. It has a collaboration with the University of Pennsylvania and the Children's Hospital of Philadelphia; Nanjing IASO Biotherapeutics Co., Ltd; Oxford Biomedica; and WuXi Advanced Therapies, Inc. The company was formerly known as Tycho Therapeutics, Inc. and changed its name to Cabaletta Bio, Inc. in August 2018. Cabaletta Bio, Inc. was incorporated in 2017 and is headquartered in Philadelphia, Pennsylvania.MSP Recovery NASDAQ:MSPR$1.27 -0.12 (-8.63%) As of 06/20/2025 04:00 PM EasternMSP Recovery, Inc. engages in the development of healthcare recoveries and data analytics software. It also focuses on the identification and recoveries of improper payments made by Medicare, Medicaid, and commercial insurance spaces using data and analytics. The company was founded by John H. Ruiz, Frank C. Quesada, and Diana Diaz on July 8, 2014 and is headquartered in Miami, FL.NantHealth NASDAQ:NH$0.01 +0.01 (+9,900.00%) As of 06/20/2025NantHealth, Inc. engages in the provision of enterprise solutions that help businesses transform complex data into actionable insights. It is also involved in marketing solutions as a comprehensive integrated solution that includes clinical decision support, payer engagement solutions, data analysis, and network monitoring and management. The company was founded by Patrick Soon-Shiong on July 7, 2010 and is headquartered in Morrisville, NC.So-Young International NASDAQ:SY$1.17 +0.16 (+15.84%) Closing price 06/20/2025 04:00 PM EasternExtended Trading$1.15 -0.02 (-1.71%) As of 06/20/2025 07:37 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.So-Young International Inc. operates an online platform for consumption healthcare services in the People's Republic of China. The company offers So-Young Mobile App that offers users medical aesthetic knowledge and experience to reach an informed medical aesthetic treatment decision and make reservations for treatment with medical professionals and medical aesthetic institutions; So-Young Beauty which provides similar interfaces and functions as the mobile app, as well as serves as additional access points to the platform; and medical aesthetic community content through its website soyoung.com. It provides content in various media formats on its online platform generated by users, including professional generated, content from in-house editorial team that shares opinions on specific new medical procedures and trends; user generated content comprising Beauty Diaries that provides details about medical institution, doctor, price, and other information on the treatment; professional user generated, contents from the medical aesthetic influencers; and doctor generated, content from doctors to generate knowledge. In addition, the company offers consumption healthcare services, including dermatology, dentistry and orthodontics, physical examinations, gynecology, and postnatal care; reservation services; and software as a service. Further, it engages in research and development, production, sales, and agency of laser and other optoelectronic medical beauty equipment; manufacture and sells light therapy device, surgical laser device and other equipment; internet information and technology advisory; online medical treatment and consultation; management consulting; internet culture; micro finance services, as well as sells cosmetics products. The company was founded in 2013 and is headquartered in Beijing, China. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas New All-Time Highs Coming for Broadcom? Wall Street Says Yes Smith & Wesson Stock Falls on Earnings Miss, Tariff Woes Marvell's New AI Chip Deals Capture Wall Street’s Attention Super Micro Computer Stock's Rally Backed by Strong Financials Forget the Fed: Home Depot Is the Real Gauge of the U.S. Consumer GE Aerospace Turns Engines Into Long-Term Profits 3 Reasons AMD Could Be the Hottest Stock of the Summer Analysts Keep Boosting Taiwan Semiconductor Stock—Here's Why Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
